Jostein Holtlund

1.0k total citations
25 papers, 893 citations indexed

About

Jostein Holtlund is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jostein Holtlund has authored 25 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Jostein Holtlund's work include PARP inhibition in cancer therapy (6 papers), RNA and protein synthesis mechanisms (4 papers) and DNA Repair Mechanisms (3 papers). Jostein Holtlund is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), RNA and protein synthesis mechanisms (4 papers) and DNA Repair Mechanisms (3 papers). Jostein Holtlund collaborates with scholars based in Norway and Germany. Jostein Holtlund's co-authors include S. Laland, T. Lund, Tom Kristensen, Berit Johne, Einar Mørk, H. Schjønsby, B Behnke, Andreas Ludwig, Helmuth Hilz and Frank Brosstad and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Jostein Holtlund

25 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jostein Holtlund Norway 16 518 205 123 120 91 25 893
J Kiil Denmark 11 327 0.6× 87 0.4× 33 0.3× 231 1.9× 187 2.1× 33 868
Irene Martínez‐Martínez Spain 21 479 0.9× 76 0.4× 71 0.6× 108 0.9× 63 0.7× 60 1.1k
Nicola Altamura Italy 21 715 1.4× 73 0.4× 70 0.6× 58 0.5× 137 1.5× 51 1.2k
Katsuro Yagawa Japan 17 189 0.4× 161 0.8× 29 0.2× 180 1.5× 65 0.7× 56 752
Iris M. De Cuyper Netherlands 16 148 0.3× 100 0.5× 32 0.3× 143 1.2× 98 1.1× 26 692
Yumiko Sakai Japan 14 291 0.6× 74 0.4× 112 0.9× 29 0.2× 54 0.6× 34 620
Sol Schulman United States 11 486 0.9× 44 0.2× 179 1.5× 79 0.7× 37 0.4× 22 861
J. C. Koningsberger Netherlands 12 242 0.5× 70 0.3× 312 2.5× 231 1.9× 156 1.7× 19 868
N R Shulman United States 11 329 0.6× 41 0.2× 60 0.5× 88 0.7× 118 1.3× 15 1.4k
Nicole M. Anders United States 19 313 0.6× 127 0.6× 22 0.2× 67 0.6× 118 1.3× 43 876

Countries citing papers authored by Jostein Holtlund

Since Specialization
Citations

This map shows the geographic impact of Jostein Holtlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jostein Holtlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jostein Holtlund more than expected).

Fields of papers citing papers by Jostein Holtlund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jostein Holtlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jostein Holtlund. The network helps show where Jostein Holtlund may publish in the future.

Co-authorship network of co-authors of Jostein Holtlund

This figure shows the co-authorship network connecting the top 25 collaborators of Jostein Holtlund. A scholar is included among the top collaborators of Jostein Holtlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jostein Holtlund. Jostein Holtlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holtlund, Jostein, et al.. (2000). Improved assay for fecal calprotectin. Clinica Chimica Acta. 292(1-2). 41–54. 188 indexed citations
2.
Johne, Berit, et al.. (1995). Colloidal gold conjugated monoclonal antibodies, studied in the BIAcore biosensor and in the Nycocard immunoassay format. Journal of Immunological Methods. 183(1). 167–174. 32 indexed citations
3.
Gogstad, Geir O., et al.. (1994). Comparison of Three D-Dimer Assays for the Diagnosis of DVT: ELISA, Latex and an Immunofiltration Assay (NycoCard D-Dimer). Thrombosis and Haemostasis. 71(3). 270–274. 68 indexed citations
4.
Mørk, Einar, et al.. (1989). The amino acid sequence of the chromosomal protein HMG-Y, its relation to HMG-I and possible domains for the preferential binding of the proteins to stretches of A-T base pairs. Biochemical and Biophysical Research Communications. 158(3). 646–651. 17 indexed citations
5.
Ingebrigtsen, Kristian, et al.. (1989). On the presence of the chromosomal proteins HMG I and HMG Y in rat organs. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1009(3). 277–279. 16 indexed citations
6.
Ludwig, Andreas, B Behnke, Jostein Holtlund, & Helmuth Hilz. (1988). Immunoquantitation and size determination of intrinsic poly(ADP-ribose) polymerase from acid precipitates. An analysis of the in vivo status in mammalian species and in lower eukaryotes.. Journal of Biological Chemistry. 263(15). 6993–6999. 80 indexed citations
7.
Lund, T., Bjørn Steen Skålhegg, Jostein Holtlund, S. Laland, & Heidi Kiil Blomhoff. (1987). Fractionation and identification of metaphase-specific phosphorylated forms of high-mobility-group proteins. European Journal of Biochemistry. 166(1). 21–26. 24 indexed citations
8.
Lund, T., Knut Helkås Dahl, Einar Mørk, Jostein Holtlund, & S. Laland. (1987). The human chromosomal protein HMG I contains two identical palindrome amino acid sequences. Biochemical and Biophysical Research Communications. 146(2). 725–730. 44 indexed citations
9.
10.
Lund, T., Jostein Holtlund, & S. Laland. (1985). On the phosphorylation of low molecular mass HMG (high mobility group) proteins in Ehrlich ascites cells. FEBS Letters. 180(2). 275–279. 52 indexed citations
11.
Holtlund, Jostein, et al.. (1985). A novel, highly phosphorylated protein, of the high‐mobility group type, present in a variety of proliferating and non‐proliferating mammalian cells. European Journal of Biochemistry. 153(3). 469–475. 33 indexed citations
12.
Holtlund, Jostein, et al.. (1983). ADP‐Ribosylation in Permeable HeLa S3 Cells. European Journal of Biochemistry. 130(1). 47–51. 7 indexed citations
13.
Holtlund, Jostein, Rune Jemtland, & Tom Kristensen. (1983). Two Proteolytic Degradation Products of Calf‐Thymus Poly(ADP‐ribose) Polymerase Are Efficient ADP‐ribose Acceptors. European Journal of Biochemistry. 130(2). 309–314. 21 indexed citations
14.
Lund, T., et al.. (1983). On the presence of two new high mobility group‐like proteins in HeLa S3 cells. FEBS Letters. 152(2). 163–167. 146 indexed citations
15.
Lund, T., Jostein Holtlund, Tom Kristensen, et al.. (1981). HMG 17 in metaphase‐arrested and interphase HeLa S3 cells. FEBS Letters. 133(1). 84–88. 10 indexed citations
16.
Kristensen, Tom & Jostein Holtlund. (1980). Chromatography of chromatin proteins on Cibacron Blue F3G-A-agarose. Journal of Chromatography A. 192(2). 494–499. 7 indexed citations
17.
Holtlund, Jostein, et al.. (1980). On the presence of poly(ADP‐ribose) polymerase activity in metaphase chromosomes from HeLa S3 cells. FEBS Letters. 116(1). 11–13. 11 indexed citations
18.
Holtlund, Jostein, Tom Kristensen, & Knut Sletten. (1980). Poly(ADP-ribose) polymerase from Ehrlich ascites-tumour cells. Amino acid composition, N-terminal analysis and chemical cleavage of the purified protein. Biochemical Journal. 185(3). 779–782. 10 indexed citations
19.
Holtlund, Jostein & Tom Kristensen. (1978). A method for density gradient isoelectric focusing in small scale. Analytical Biochemistry. 87(2). 425–432. 10 indexed citations
20.
Kristensen, Tom & Jostein Holtlund. (1976). Purification of Poly(ADP‐ribose) Polymerase from Ehrlich Ascites Tumor Cells by Chromatography on DNA‐Agarose. European Journal of Biochemistry. 70(2). 441–446. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Kiil Breakdown of academic impact, for papers by Irene Martínez‐Martínez Breakdown of academic impact, for papers by Nicola Altamura Breakdown of academic impact, for papers by Katsuro Yagawa Breakdown of academic impact, for papers by Iris M. De Cuyper Breakdown of academic impact, for papers by Yumiko Sakai Breakdown of academic impact, for papers by Sol Schulman Breakdown of academic impact, for papers by J. C. Koningsberger Breakdown of academic impact, for papers by N R Shulman Breakdown of academic impact, for papers by Nicole M. Anders
Rankless by CCL
2026